Cargando…
Evaluating determinants of receipt of molecular imaging in biochemical recurrent prostate cancer
BACKGROUND: Molecular imaging with novel radiotracers is changing the treatment landscape in prostate cancer (PCa). Currently, standard of care includes either conventional and molecular imaging at time of biochemical recurrence (BCR). This study evaluated the determinants of and cost associated wit...
Autores principales: | Borno, Hala T., Kuo Lin, Tracy, Odisho, Anobel Y., Desai, Arpita, Koshkin, Vadim, Werner, Kalin, Legaspi, Nichole, Bucknor, Matthew, Bell, Alexander, Zhang, Sylvia, Hope, Thomas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826487/ https://www.ncbi.nlm.nih.gov/pubmed/33247633 http://dx.doi.org/10.1002/cam4.3555 |
Ejemplares similares
-
COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry
por: Borno, Hala T, et al.
Publicado: (2022) -
Development of CNS-type Primitive Neuroectodermal Tumor in Metastatic Testicular Mixed Germ Cell Tumor
por: Odisho, Anobel Y., et al.
Publicado: (2016) -
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer
por: Freeman, Meredith N, et al.
Publicado: (2022) -
Innovative surgical techniques for managing Peyronie’s disease: a video presentation
por: Odisho, Anobel Y., et al.
Publicado: (2013) -
Regional and temporal variation in receipt of long‐term opioid therapy among older breast, colorectal, lung, and prostate cancer survivors in the United States
por: Gibson, Derrick C., et al.
Publicado: (2021)